readthroughSign in
CompanyREGNNasdaqTarrytown, NY

Regeneron Pharmaceuticals

Regeneron develops monoclonal antibodies and bispecific antibodies for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.

10-QNov 16Latest SEC filing
Nov 12Latest story

November 2026

October 2026

September 2026

August 2026

July 2026